<SEC-DOCUMENT>0001104659-25-091366-index.html : 20250918
<SEC-HEADER>0001104659-25-091366.hdr.sgml : 20250918
<ACCEPTANCE-DATETIME>20250918184808
ACCESSION NUMBER:		0001104659-25-091366
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250918
DATE AS OF CHANGE:		20250918

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Telomir Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001971532
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				872606031
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-95236
		FILM NUMBER:		251324607

	BUSINESS ADDRESS:	
		STREET 1:		100 SE 2ND ST
		STREET 2:		SUITE 2000 #1009
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33131
		BUSINESS PHONE:		786-396-6723

	MAIL ADDRESS:	
		STREET 1:		100 SE 2ND ST
		STREET 2:		SUITE 2000 #1009
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33131

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DEJORIA JOHN PAUL
		CENTRAL INDEX KEY:			0000897610
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	MAIL ADDRESS:	
		STREET 1:		2934 OESTRICK LANE
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78733
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>tm2526490d1_ex24-1.htm
<DESCRIPTION>EXHIBIT 24.1
<TEXT>
Document 2 - file: tm2526490d1_ex24-1.htm

</DOCUMENT>
</SEC-DOCUMENT>